Neuland Laboratories to open Hyderabad commercial peptide facility The CDMO’s Module 1 commercial production module to be operational by summer 2026 as part of its planned phased expansion.

Neuland Laboratories to open Hyderabad commercial peptide facility, with the CDMO’s new commercial production module expected to be operational by summer 2026.

www.europeanpharmaceuticalreview.com/news/272047/...

#pharma #CDMO #CDMOs

Charles River Laboratories parts ways with its CDMO business Aims to further strengthen and broaden its portfolio in order to drive long-term growth, greater efficiency and operational excellence.

Charles River Laboratories parts ways with its contract manufacturing business and hatches plans to sell some of its European discovery services

www.europeanpharmaceuticalreview.com/news/271717/...

#pharma #manufacturing #CDMO #CDMOs

This week on EPR: J&J’s manufacturing investment, FDA’s trial rule change and approvals for GSK and Amgen Welcome to EPR’s latest LinkedIn newsletter. Each week we share news, analysis and resources from across the biopharma sector, with a focus on the industry’s manufacturing and research work.

J&J’s US investment in cell therapy manufacturing, GSK and Amgen product approvals, the FDA’s clinical trial rule changes and more feature in the latest issue of EPR's weekly newsletter.

www.linkedin.com/pulse/week-e...

#pharma #manufacturing #CDMO #CDMOs

#LifeSciencesPodcast #USExecutiveOrder #APIs #PharmaManufacturing #CDMOs #Podcast #BWSMarketing #BWSDialogues

Ofichem acquires Uppsala site from Meribel Pharma Solutions The deal between the two European CDMOs expands Ofichem’s Nordic biotech footprint and drug substance capabilities.

Ofichem acquires Uppsala site from Meribel Pharma Solutions, expanding the European CDMO’s Nordic biotech footprint and drug substance capabilities

www.europeanpharmaceuticalreview.com/news/264392/...

#pharma #manufacturing #CDMOs

Quotient Sciences News John McDermott Contributes to Pharmaceutical Outsourcing Oral Solid Dosage Roundtable

In this article from Pharmaceutical Outsourcing, John McDermott, VP of Scientific Consulting, talks about the evolving landscape of oral solid dosage manufacturing and highlights the importance of small, agile #CDMOs to meet the diverse demands of modern #drugdevelopment. bit.ly/4lmAjHd